Physician profile
Nathan C Jackson
NPI 1447828728
$2,691.18
in general payments reported to CMS, 2019-2025
14 companies · $236 in 2025
The $236 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $174 · 2022: $397 · 2023: $1,774 · 2024: $110 · 2025: $236.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,107 · Travel and Lodging: $935 · Entertainment: $78.55.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,106.97 |
| Travel and Lodging | $934.53 |
| Entertainment | $78.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,381.05 | 2022-2025 | Total30, Precision7, Precision 7 |
| Oyster Point Pharma, INC. | $203.81 | 2022-2023 | Tyrvaya |
| Abbvie INC. | $195.69 | 2022-2023 | |
| Tarsus Pharmaceuticals, INC. | $168.06 | 2025 | Xdemvy |
| Biotissue Holdings INC. | $147.42 | 2023 | |
| Kala Pharmaceuticals, INC. | $121.75 | 2021 | |
| Novartis Pharmaceuticals Corporation | $118.29 | 2021-2023 | |
| Sun Pharmaceutical Industries INC. | $100.31 | 2021-2023 | Cequa |
| Optos, INC. | $78.55 | 2023 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Johnson & Johnson Vision Care, INC. | $67.83 | 2024 | |
| Coopervision INC. | $46.83 | 2025 | Myday Contact Lens |
| Bausch & Lomb Americas INC. | $24.30 | 2023 | Vyzulta |
| Horizon Therapeutics Plc | $19.78 | 2023 | Tepezza |
| Aerie Pharmaceuticals, INC. | $17.51 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nathan Jackson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.